Resource Center
Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
De-Risking FIH: Integrated Strategies for Rapid Proof-of-Concept
Download223 - 228 of 232 results
Strategies for Accelerating Pediatric Drug Development
Formulation Development and a Phase 1 Clinical Study of PF614-MPAR, an Oxycodone Prodrug with Oral Opioid Overdose Protection
How to Capture Growth in the Expanding Metabolic Drug Market
Translational Pharmaceutics® for First-in-Human Studies
Assessing the Financial Impact of Translational Pharmaceutics® - Tufts CSDD Report
AAPS 2021: Pharmaceutical and clinical performance comparisons of modified release multiparticulates and matrix tablet formulations
Learn about Quotient Sciences' services
Where integrated CRDMO services bring therapies to life. Whether it's meeting your first-in-human milestone, confidently advancing your program to proof-of-concept, or providing a trusted supply of clinical trial materials or commercial drug product, learn about Quotient Sciences CRDMO offering and how we can support your next drug program.